We provide you with 20 years of free, institutional-grade data for CERT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CERT. Explore the full financial landscape of CERT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$559,366
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Pedersen Leif E | Sale | -51,224 | $10.92 | $559,366 | 2025-09-11 |
Corcoran Daniel | Sale | -6,607 | $11.4 | $75,320 | 2025-06-02 |
Corcoran Daniel | Derivatives Exercise | 7,940 | 2025-06-02 | ||
Anhalt Rona | Sale | -1,965 | $11.4 | $22,401 | 2025-06-02 |
Anhalt Rona | Derivatives Exercise | 7,146 | 2025-06-02 | ||
Collins Cynthia | Derivatives Exercise | 11,928 | 2025-05-22 | ||
CASHMAN JAMES E III | Derivatives Exercise | 11,928 | 2025-05-22 | ||
BROSHY ERAN | Derivatives Exercise | 11,928 | 2025-05-22 | ||
Reynders John V W | Derivatives Exercise | 10,709 | 2025-05-22 | ||
Killefer Nancy | Derivatives Exercise | 11,928 | 2025-05-22 | ||
Crane Rosemary A | Derivatives Exercise | 11,928 | 2025-05-22 | ||
WALSH MATTHEW M | Derivatives Exercise | 11,928 | 2025-05-22 | ||
Aspbury Robert | Derivatives Exercise | 26,626 | 2025-04-03 | ||
Aspbury Robert | Sale | -15,846 | $9.9 | $156,875 | 2025-04-03 |
Aspbury Robert | Grant, award...etc | 7,082 | 2025-04-03 | ||
Gallagher John E | Sale | -14,176 | $9.9 | $140,342 | 2025-04-03 |
Gallagher John E | Derivatives Exercise | 42,486 | 2025-04-03 | ||
Pedersen Leif E | Derivatives Exercise | 26,626 | 2025-04-03 | ||
Pedersen Leif E | Sale | -8,209 | $9.9 | $81,269 | 2025-04-03 |
Pedersen Leif E | Grant, award...etc | 7,082 | 2025-04-03 | ||
Feehery William F | Derivatives Exercise | 111,393 | 2025-04-03 | ||
Feehery William F | Sale | -53,834 | $9.9 | $532,957 | 2025-04-03 |
Feehery William F | Grant, award...etc | 29,960 | 2025-04-03 | ||
SMITH PATRICK F | Sale | -5,409 | $11.03 | $59,661 | 2024-10-08 |
SMITH PATRICK F | Sale | -1,742 | $10.99 | $19,145 | 2024-10-07 |
SMITH PATRICK F | Derivatives Exercise | 7,151 | 2024-10-07 | ||
Pedersen Leif E | Sale | -51,224 | $11.29 | $578,319 | 2024-09-10 |
Aspbury Robert | Sale | -862 | $13.85 | $11,939 | 2024-07-02 |
CASHMAN JAMES E III | Derivatives Exercise | 8,663 | 2024-05-23 | ||
BROSHY ERAN | Derivatives Exercise | 8,663 | 2024-05-23 | ||
Crane Rosemary A | Derivatives Exercise | 8,663 | 2024-05-23 | ||
Collins Cynthia | Derivatives Exercise | 8,663 | 2024-05-23 | ||
Killefer Nancy | Derivatives Exercise | 8,663 | 2024-05-23 | ||
WALSH MATTHEW M | Derivatives Exercise | 8,663 | 2024-05-23 | ||
SMITH PATRICK F | Sale | -14,427 | $16.76 | $241,797 | 2024-04-04 |
Pedersen Leif E | Derivatives Exercise | 16,498 | 2024-04-03 | ||
Pedersen Leif E | Sale | -5,951 | $17.88 | $106,404 | 2024-04-03 |
Gallagher John E | Sale | -9,077 | $17.88 | $162,297 | 2024-04-03 |
Gallagher John E | Derivatives Exercise | 27,295 | 2024-04-03 | ||
Aspbury Robert | Derivatives Exercise | 16,498 | 2024-04-03 | ||
Aspbury Robert | Sale | -10,625 | $17.88 | $189,975 | 2024-04-03 |
Feehery William F | Derivatives Exercise | 69,799 | 2024-04-03 | ||
Feehery William F | Sale | -42,629 | $17.88 | $762,207 | 2024-04-03 |
Traynor Richard M. | Derivatives Exercise | 13,295 | 2024-04-03 | ||
Traynor Richard M. | Sale | -9,244 | $17.88 | $165,283 | 2024-04-03 |
SMITH PATRICK F | Derivatives Exercise | 16,498 | 2024-04-03 | ||
SMITH PATRICK F | Sale | -6,955 | $17.88 | $124,355 | 2024-04-03 |
SHERMAN NICOLETTE D | Sale | -2,578 | $17.88 | $46,095 | 2024-04-03 |
SHERMAN NICOLETTE D | Derivatives Exercise | 8,219 | 2024-04-03 | ||
Aspbury Robert | Sale | -7,311 | $18.88 | $138,032 | 2024-03-06 |
Aspbury Robert | Grant, award...etc | 15,549 | 2024-03-06 | ||
Pedersen Leif E | Sale | -4,050 | $18.88 | $76,464 | 2024-03-06 |
Pedersen Leif E | Grant, award...etc | 15,548 | 2024-03-06 | ||
SHERMAN NICOLETTE D | Sale | -2,373 | $18.88 | $44,802 | 2024-03-06 |
SHERMAN NICOLETTE D | Grant, award...etc | 6,600 | 2024-03-06 | ||
Traynor Richard M. | Sale | -3,660 | $18.88 | $69,101 | 2024-03-06 |
Traynor Richard M. | Grant, award...etc | 10,765 | 2024-03-06 | ||
Feehery William F | Sale | -17,557 | $18.88 | $331,476 | 2024-03-06 |
Feehery William F | Grant, award...etc | 59,799 | 2024-03-06 | ||
Traynor Richard M. | Sale | -3,000 | $18.28 | $54,840 | 2024-03-05 |
SMITH PATRICK F | Sale | -5,000 | $18 | $90,000 | 2024-02-21 |
Traynor Richard M. | Sale | -6,000 | $18 | $108,000 | 2024-02-14 |
Traynor Richard M. | Sale | -6,000 | $18 | $108,000 | 2023-12-27 |
Pedersen Leif E | Sale | -51,224 | $14.6 | $747,870 | 2023-09-12 |
BROSHY ERAN | Open Market Purchase | 5,000 | $16.1 | 2023-08-23 | |
SHERMAN NICOLETTE D | Sale | -1,057 | $19.47 | $20,580 | 2023-08-02 |
Aspbury Robert | Sale | -862 | $18.19 | $15,680 | 2023-07-03 |
SMITH PATRICK F | Sale | -19,104 | $21.55 | $411,691 | 2023-06-06 |
BROSHY ERAN | Derivatives Exercise | 9,360 | 2023-05-25 | ||
Crane Rosemary A | Derivatives Exercise | 9,324 | 2023-05-25 | ||
WALSH MATTHEW M | Derivatives Exercise | 9,067 | 2023-05-19 | ||
Collins Cynthia | Derivatives Exercise | 9,067 | 2023-05-19 | ||
CASHMAN JAMES E III | Derivatives Exercise | 9,067 | 2023-05-18 | ||
Killefer Nancy | Derivatives Exercise | 9,067 | 2023-05-18 | ||
Traynor Richard M. | Sale | -5,000 | $20.82 | $104,100 | 2023-05-15 |
Traynor Richard M. | Sale | -5,000 | $23.66 | $118,300 | 2023-04-17 |
Feehery William F | Derivatives Exercise | 36,580 | 2023-04-03 | ||
Feehery William F | Sale | -25,634 | $23.8 | $610,089 | 2023-04-03 |
Aspbury Robert | Derivatives Exercise | 8,646 | 2023-04-03 | ||
Aspbury Robert | Sale | -6,934 | $23.8 | $165,029 | 2023-04-03 |
Schemick Michael Andrew | Derivatives Exercise | 13,302 | 2023-04-03 | ||
Schemick Michael Andrew | Sale | -8,277 | $23.8 | $196,993 | 2023-04-03 |
Virkler Drayton | Sale | -1,166 | $23.8 | $27,751 | 2023-04-03 |
Virkler Drayton | Derivatives Exercise | 3,990 | 2023-04-03 | ||
SHERMAN NICOLETTE D | Sale | -1,251 | $23.8 | $29,774 | 2023-04-03 |
SHERMAN NICOLETTE D | Derivatives Exercise | 3,990 | 2023-04-03 | ||
SMITH PATRICK F | Derivatives Exercise | 8,646 | 2023-04-03 | ||
SMITH PATRICK F | Sale | -4,426 | $23.8 | $105,339 | 2023-04-03 |
Traynor Richard M. | Derivatives Exercise | 6,651 | 2023-04-03 | ||
Traynor Richard M. | Sale | -3,847 | $23.8 | $91,559 | 2023-04-03 |
Pedersen Leif E | Derivatives Exercise | 8,646 | 2023-04-03 | ||
Pedersen Leif E | Sale | -4,039 | $23.8 | $96,128 | 2023-04-03 |
Traynor Richard M. | Sale | -10,000 | $21.45 | $214,500 | 2023-03-07 |
Traynor Richard M. | Sale | -15,000 | $20 | $300,000 | 2023-02-03 |
EQT Avatar Parent L.P. | Sale | -29,954,521 | $15 | $449,317,815 | 2022-12-12 |
Pedersen Leif E | Sale | -51,223 | $15.55 | $796,518 | 2022-11-23 |
SLAINE MASON P | Sale | -250,000 | $15.27 | $3,817,500 | 2022-11-16 |
WALSH MATTHEW M | Sale | -12,059 | $14.74 | $177,750 | 2022-11-15 |
SMITH PATRICK F | Sale | -2,387 | $13.48 | $32,177 | 2022-11-14 |
SMITH PATRICK F | Sale | -1,244 | $12.23 | $15,214 | 2022-11-02 |
Virkler Drayton | Sale | -4,004 | $13.31 | $53,293 | 2022-10-04 |
Virkler Drayton | Derivatives Exercise | 13,595 | 2022-10-04 | ||
McLean Stephen M. | Open Market Purchase | 20,000 | $16.32 | 2022-08-23 | |
Schemick Michael Andrew | Open Market Purchase | 25,000 | $16.64 | 2022-08-18 | |
SMITH PATRICK F | Sale | -10,000 | $17.71 | $177,100 | 2022-08-18 |
EQT Avatar Parent L.P. | Sale | -6,004,418 | $17.38 | $104,356,785 | 2022-08-17 |
SLAINE MASON P | Sale | -182,475 | $17.38 | $3,171,416 | 2022-08-17 |
SHERMAN NICOLETTE D | Sale | -2,812 | $22.99 | $64,648 | 2022-08-02 |
Aspbury Robert | Sale | -884 | $21.46 | $18,971 | 2022-07-05 |
SLAINE MASON P | Sale | -250,000 | $19.55 | $4,887,500 | 2022-06-03 |
The information provided in this report about CERT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Certara, Inc(NASDAQ:CERT)


Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug disco...
Website: https://www.certara.com/
Founded: 2008
CEO: William F. Feehery Ph.D.
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends